Sign In
Buy ZTS
$77.59
+1.20 (+1.57%)
At Close: Jun 03, 2026
Final Trades: Zoetis, Costco, Disney & more
02:22pm, Friday, 27'th May 2022
The "Halftime Report" traders give their top picks to watch for the second half.
ASRT vs. ZTS: Which Stock Should Value Investors Buy Now?
12:48pm, Thursday, 26'th May 2022
ASRT vs. ZTS: Which Stock Is the Better Value Option?
Zoetis: Animal Health Leader Now Cheapest Since April 2021
04:16pm, Friday, 20'th May 2022
Zoetis: Animal Health Leader Now Cheapest Since April 2021
Polen Focus Growth Q1 2022 Portfolio Manager Commentary
04:22am, Saturday, 14'th May 2022 Seeking Alpha
During Q1 2022, the Polen Focus Growth Composite Portfolio returned -13.39% and -13.56%, gross and net of fees, respectively. Click here to read the full fund letter.
Vanguard Health Care Fund's Top 5 Trades in the 1st Quarter
05:05pm, Monday, 09'th May 2022
The Vanguard Health Care Fund (Trades, Portfolio) recently disclosed its first quarter 2022 portfolio, revealing that its top five trades for the quarter included a new position in Zoetis Inc. ( ZTS ,
7 Defensive Dividend Healthcare Stocks to Buy Now
07:33am, Friday, 06'th May 2022
As market conditions remain rocky, adding high-quality healthcare stocks to your portfolio may be a great way to play defense. The post 7 Defensive Dividend Healthcare Stocks to Buy Now appeared first
Zoetis (ZTS) Q1 2022 Earnings Call Transcript
05:30am, Friday, 06'th May 2022 The Motley Fool
ZTS earnings call for the period ending March 31, 2022.
Zoetis' (ZTS) Q1 Earnings and Revenues Surpass Estimates
03:07pm, Thursday, 05'th May 2022 Zacks Investment Research
Zoetis' (ZTS) earnings and revenues trump estimates in the first quarter of 2022.
Zoetis Inc. (ZTS) CEO Kristin Peck on Q1 2022 Results - Earnings Call Transcript
01:50pm, Thursday, 05'th May 2022
Zoetis Inc. (NYSE:ZTS ) Q1 2022 Earnings Conference Call May 5, 2022 8:30 AM ET Company Participants Steve Frank - VP, IR Kristin Peck - CEO Wetteny Joseph - CFO Conference Call Participants Erin Wrig
Zoetis' (ZTS) Q1 Earnings and Revenues Surpass Estimates
12:47pm, Thursday, 05'th May 2022
Zoetis' (ZTS) earnings and revenues trump estimates in the first quarter of 2022.
Zoetis (ZTS) Tops Q1 Earnings and Revenue Estimates
12:25pm, Thursday, 05'th May 2022 Zacks Investment Research
Zoetis (ZTS) delivered earnings and revenue surprises of 8.20% and 0.88%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zoetis (ZTS) Tops Q1 Earnings and Revenue Estimates
09:47am, Thursday, 05'th May 2022
Zoetis (ZTS) delivered earnings and revenue surprises of 8.20% and 0.88%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Drug/Biotech Stocks Q1 Earnings Due on May 5: VRTX, ZTS & More
07:19pm, Wednesday, 04'th May 2022 Zacks Investment Research
Let's look at the five biotech/drug companies, slated to release quarterly results on May 5.
Drug/Biotech Stocks Q1 Earnings Due on May 5: VRTX, ZTS & More
04:33pm, Wednesday, 04'th May 2022
Let's look at the five biotech/drug companies, slated to release quarterly results on May 5.
CNBC's Final Trades: Zoetis, VanEck Gold Miners ETF, Paramount Global And This Energy Stock
11:57am, Tuesday, 03'rd May 2022 Benzinga
On CNBC’s “Halftime Report Final Trades,” Brenda Vingiello of Sand Hill Global Advisors said Zoetis Inc (NYSE: ZTS) is “the largest provider of vaccines and medicines for pets and livestock.�
